3B BlackBio Dx schedules one-on-one investor call for September 11
- 3B BlackBio Dx hosts virtual investor call on September 11, 2026
- One-on-one meeting scheduled with Capri Global Holdings
- Company to use Q1-FY27 investor presentation for discussion
- Disclosure made under Regulation 30 of SEBI LODR Regulations

*this image is generated using AI for illustrative purposes only.
3B BlackBio Dx Limited will host a virtual investor conference call on Friday, September 11, 2026, at 11:00 am. The meeting is scheduled as a one-on-one interaction with Capri Global Holdings in Mumbai.
The company disclosed the schedule pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The interaction will be conducted via an investor conference call mode.
Meeting Details
The company confirmed that only information available in the public domain will be shared during the session. No unpublished price-sensitive information will be discussed.
| Parameter | Details |
|---|---|
| Date and Time | September 11, 2026 at 11:00 am |
| Counterparty | Capri Global Holdings, Mumbai |
| Mode | Virtual Investor Conference Call |
| Type | One-on-One |
Presentation Material
For this meeting, the company will use the Investor Presentation of Q1-FY27. This document was previously intimated to the stock exchange vide Ref.No.P-66/2026-27/27 dated August 13, 2026.
The disclosure was signed by Nikhil Kuber Dubey, Whole Time Director of 3B BlackBio Dx Limited (formerly Kilpest India Limited). The company noted that the date and time are subject to change due to exigencies on the part of the investor or the company.
Historical Stock Returns for 3B BlackBio DX
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.76% | +8.13% | +16.99% | 0.0% | 0.0% | 0.0% |
How might the one-on-one engagement with Capri Global Holdings signal potential strategic partnerships or M&A activity for 3B BlackBio Dx?
What specific growth drivers in the Q1-FY27 investor presentation are likely to influence Capri Global Holdings' investment thesis for the company?
Could this targeted investor interaction indicate a broader shift in 3B BlackBio Dx's capital raising strategy or institutional outreach efforts?


































